| NDC Code | 0093-7104-56 |
|---|
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0093-7104-56) |
|---|
| Product NDC | 0093-7104 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Tenofovir Disoproxil Fumarate |
|---|
| Non-Proprietary Name | Tenofovir Disoproxil Fumarate |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20171215 |
|---|
| End Marketing Date | 20191130 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA091612 |
|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
|---|
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
|---|